Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

Completed

Conditions studied: Alcohol Withdrawal Syndrome

In brief

The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.

Key facts

Study ID

NCT01652326

Run by

University of Pittsburgh

People needed

792

Starts

2012-07-01

Expected to finish

2015-09-01

Last updated by the study team

2016-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• either
• a requirement of either 200 mg of diazepam (or diazepam equivalents) in 4 hrs;
• > 40mg of diazepam (or diazepam equivalents) in 1 hr; or
• an individual dose of 40 mg or greater of intravenous diazepam for control of agitation

You may not qualify if…

• if < 18 years of age or had evidence of use of other illicit substances as determined by urine toxicology screen

Where it is running

• UPMC — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.